A window-of-opportunity trial of the CXCR1/2 inhibitor reparixin in operable HER-2-negative breast cancer

Breast Cancer Research

January 10, 2020

10.1186/s13058-019-1243-8

Cited by 137

Related Papers

No related papers found

Powered by citation graph analysis